ASPECCT_3A: ASPECCT, figure 3A

ASPECCT_3AR Documentation

ASPECCT, figure 3A

Description

Kaplan-Meier digitized data from ASPECCT, figure 3A (PMID 24739896). A reported sample size of 1,010 for a primary endpoint of OS in colorectal cancer.

Usage

ASPECCT_3A

Format

A data frame of 999 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (cetuximab, panitumumab)

Source

Price TJ, Peeters M, Kim TW, et al. Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study. Lancet Oncol 2014; 15: 569–79.

Examples

summary(ASPECCT_3A)

kmplot(ASPECCT_3A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.